Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
13 results
  • Cellular Therapy, Prostate Cancer

20-075          Phase I

A Phase 1 Dose Escalation and Expanded Cohort Study of P-PSMA-101 in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (View details on clinicaltrial.gov)

  • Prostate Cancer, Liver Cancer, Head and Neck Cancer, Kidney Cancer, Metastatic/Advanced Cancer, Colorectal Cancer, Breast Cancer

19-427          Phase I

A Phase 1 dose escalation study evaluating safety, tolerability and pharmacokinetics of PF-06952229 in adult patients with advanced solid tumors. (View details on clinicaltrial.gov)

  • Prostate Cancer

19-618          Phase I

A Phase 1 Open-label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Tolerability, and Pharmacokinetics of HPN424 in Patients with Advanced Prostate Cancer Refractory to Androgen Therapy (View details on clinicaltrial.gov)

  • Prostate Cancer

20-435          Phase I

A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral EPI-7386 in Patients with Metastatic Castration-Resistant Prostate Cancer (View details on clinicaltrial.gov)

  • Prostate Cancer

19-060          Phase I

A Phase 1/2, open-label, dose escalation and cohort expansion clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARV-110 in patients with metastatic castration-resistant prostate cancer (View details on clinicaltrial.gov)

  • Prostate Cancer

18-117          Phase II

A Phase 2 Study of PCM-075 in Combination with Abiraterone and Prednisone in Subjects with Metastatic Castration-Resistant Prostate Cancer (View details on clinicaltrial.gov)

  • Prostate Cancer

19-241          Phase III

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer (View details on clinicaltrial.gov)

  • Prostate Cancer

20-581          Phase II

An Open-Label Phase 1b Study of ORIC-101 in Combination with Enzalutamide in Patients with Metastatic Prostate Cancer Progressing on Enzalutamide (View details on clinicaltrial.gov)

Showing 1 - 10 of 13 results